Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
 GILD | Gilead Sciences Inc | $179.5b | $159.37 | +0.2% | 3.5M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $6.4b | $14.53 | +5.8% | 7.9M |
 NTLA | Intellia Therapeutics, Inc | $1.7b | $12.15 | +9.0% | 3.2M |
 IMTX | Immatics N.V. Ordinary Shares | $1.2b | $7.24 | +1.5% | 1.1M |
 VOR | Vor Biopharma Inc. Common Stock | $1.1b | $20.34 | +6.4% | 640.5K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $2.44 | +5.1% | 2.1M |
 IMMX | Immix Biopharma, Inc. Common Stock | $0.8b | $8.05 | -0.1% | 986.6K |
 YDES | YD Bio Limited Ordinary Shares | $0.6b | $6.08 | +13.8% | 45.8K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.5b | $1.24 | +1.7% | 15.3M |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $333.9m | $4.32 | -30.8% | 8.3M |
 FATE | Fate Therapeutics, Inc. | $278.0m | $2.06 | +0.5% | 880.4K |
 IPSC | Century Therapeutics, Inc. Common Stock | $277.0m | $1.45 | +1.4% | 582.9K |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $226.9m | $10.11 | +7.8% | 96.6K |
 NKTX | Nkarta, Inc. Common Stock | $184.4m | $1.68 | -7.4% | 2.4M |
 TARA | Protara Therapeutics, Inc. Common Stock | $180.2m | $2.54 | +4.9% | 1.7M |
 CRBU | Caribou Biosciences, Inc. Common Stock | $130.8m | $0.47 | -6.8% | 2.2M |
 ENGN | enGene Therapeutics Inc. Common Stock | $130.0m | $1.55 | -1.9% | 338.4K |
 ANIX | Anixa Biosciences, Inc. | $102.6m | $3.31 | +11.3% | 480.1K |
 ATRA | Atara Biotherapeutics, Inc | $95.2m | $8.24 | -0.7% | 20.5K |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $16.39 | -0.1% | 105.9K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $63.5m | $10.60 | 0.0% | 9.8K |
 ACET | Adicet Bio, Inc. Common Stock | $60.8m | $3.83 | -4.1% | 169.9K |
 CELU | Celularity Inc. Class A Common Stock | $51.9m | $0.80 | +6.9% | 216.8K |
 TVGN | Tevogen Inc. Common Stock | $45.5m | $6.25 | 0.0% | 5.1K |
 BCTX | Briacell Therapeutics Corp. Common Shares | $37.2m | $3.56 | +3.1% | 48.9K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $21.7m | $0.19 | +1.7% | 536.5K |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $20.4m | $0.92 | -6.4% | 584.7K |
 INAB | IN8bio, Inc. Common Stock | $13.8m | $0.96 | 0.0% | 11.8K |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $11.0m | $0.87 | 0.0% | 16.9K |
 SNTI | Senti Biosciences Holdings, Inc. Common Stock | $10.0m | $0.20 | +5.5% | 56.2M |
 LNAI | Lunai Bioworks Inc. Common Stock | $5.9m | $0.24 | -10.8% | 426.9K |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $4.3m | $0.35 | -1.3% | 66.9K |
 MBIO | Mustang Bio, Inc. | $3.6m | $0.37 | 0.0% | 24.9K |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $3.5m | $1.97 | 0.0% | 7.4K |
 CLDI | Calidi Biotherapeutics, Inc. | $2.8m | $0.66 | +3.1% | 31.1K |